Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Microneedle Flu Vaccine Market, by Region, 2020-2028 (USD Million)
1.2.2. Microneedle Flu Vaccine Market, by Product Type, 2020-2028 (USD Million)
1.2.3. Microneedle Flu Vaccine Market, by Vaccine Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Microneedle Flu Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Microneedle Flu Vaccine Market Dynamics
3.1. Microneedle Flu Vaccine Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Key Players Focusing on Research and Development of Micro-Needle Flu Vaccines
3.1.1.2. Increasing Prevalence of Influenza and Viral Infections
3.1.2. Market Challenges
3.1.2.1. Complications and Risks Associated with Microneedles
3.1.3. Market Opportunities
3.1.3.1. Rising incidences of swine flu
3.1.3.2. increased risk of respiratory diseases and immune-deficient diseases
Chapter 4. Global Microneedle Flu Vaccine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Microneedle Flu Vaccine Market, by Vaccine Type
6.1. Market Snapshot
6.2. Global Microneedle Flu Vaccine Market by Vaccine Type, Performance - Potential Analysis
6.3. Global Microneedle Flu Vaccine Market Estimates & Forecasts by Vaccine Type, 2018-2028 (USD Million)
6.4. Microneedle Flu Vaccine Market, Sub Segment Analysis
6.4.1. Trivalent Flu Vaccine
6.4.2. Quadrivalent Flu Vaccine
Chapter 7. Global Microneedle Flu Vaccine Market, by Product Type
7.1. Market Snapshot
7.2. Global Microneedle Flu Vaccine Market by Product Type, Performance - Potential Analysis
7.3. Global Microneedle Flu Vaccine Market Estimates & Forecasts by Product Type, 2018-2028 (USD Million)
7.4. Microneedle Flu Vaccine Market, Sub Segment Analysis
7.4.1. Solid Microneedle
7.4.2. Hollow Microneedle
7.4.3. Coated Microneedle
7.4.4. Dissolving Microneedle
Chapter 8. Global Microneedle Flu Vaccine Market, Regional Analysis
8.1. Microneedle Flu Vaccine Market, Regional Market Snapshot
8.2. North America Microneedle Flu Vaccine Market
8.2.1. U.S. Microneedle Flu Vaccine Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. Vaccine Type breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Microneedle Flu Vaccine Market
8.3. Europe Microneedle Flu Vaccine Market Snapshot
8.3.1. U.K. Microneedle Flu Vaccine Market
8.3.2. Germany Microneedle Flu Vaccine Market
8.3.3. France Microneedle Flu Vaccine Market
8.3.4. Spain Microneedle Flu Vaccine Market
8.3.5. Italy Microneedle Flu Vaccine Market
8.3.6. Rest of Europe Microneedle Flu Vaccine Market
8.4. Asia-Pacific Microneedle Flu Vaccine Market Snapshot
8.4.1. China Microneedle Flu Vaccine Market
8.4.2. India Microneedle Flu Vaccine Market
8.4.3. Japan Microneedle Flu Vaccine Market
8.4.4. Australia Microneedle Flu Vaccine Market
8.4.5. South Korea Microneedle Flu Vaccine Market
8.4.6. Rest of Asia Pacific Microneedle Flu Vaccine Market
8.5. Latin America Microneedle Flu Vaccine Market Snapshot
8.5.1. Brazil Microneedle Flu Vaccine Market
8.5.2. Mexico Microneedle Flu Vaccine Market
8.6. Rest of The World Microneedle Flu Vaccine Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Becton, Dickinson and Company
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. 3M Company
9.2.3. CosMED Pharmaceuticals Co., Ltd.
9.2.4. OraSure Technologies, Inc.
9.2.5. NanoPass Technologies Limited
9.2.6. Corium International, Inc
9.2.7. FluGen, Inc.
9.2.8. Microdermics
9.2.9. Debiotech S.A
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption